STOCKWATCH
·
Pharmaceuticals
USFDA28 Jan 2026, 06:31 pm

Biocon Ltd Receives VAI Status from US FDA for API Facility in Andhra Pradesh

AI Summary

Biocon Ltd has announced that it has received a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration (US FDA) for their Active Pharmaceutical Ingredient (API) facility located at Plot No 95, Visakha Pharmacity, SEZ, Jawaharlal Nehru Pharma City, Paravada, Andhra Pradesh. The status was granted following an inspection conducted by the agency between 3rd and 7th November 2025.

Key Highlights

  • Biocon Ltd receives VAI status from US FDA for their API facility in Andhra Pradesh
  • The status was granted based on an inspection conducted between 3rd and 7th November 2025
  • The API facility is located at Plot No 95, Visakha Pharmacity, SEZ, Jawaharlal Nehru Pharma City, Paravada, Andhra Pradesh
BIOCON
Pharmaceuticals
BIOCON LTD.

Price Impact